ARTEEVO TECHNOLOGIES LTD

Their core work

Arteevo Technologies is an Israeli technology SME that builds blockchain-powered and cloud-based digital platforms for B2B applications. Their work spans from industrial knowledge platforms (e.g., a digital welding marketplace connecting manufacturers with equipment and consumables) to pharmaceutical supply chain integrity using blockchain and machine learning. They appear to specialize in developing decentralized, API-driven platform architectures that connect fragmented industries through shared digital infrastructure.

What they specialise in

How they've shifted over time

Arteevo's early work (2015–2019) centered on general-purpose digital platforms — online privacy tools (OPERANDO), a B2B welding knowledge platform with blockchain and cloud components (WeldGalaxy), and a decentralized travel distribution platform (GASTEJO). From 2020 onward, the company pivoted sharply toward health and pharma, joining PharmaLedger — their largest-funded project — focused on blockchain for medicines authentication and machine-learning health data marketplaces. The trajectory shows a company that refined its blockchain and platform-building skills across multiple domains before concentrating them in the high-value pharmaceutical sector.

Arteevo is moving from general-purpose platform development toward blockchain applications in regulated industries, particularly pharmaceutical supply chains and health data — expect them to deepen this health-tech focus.

How they like to work

Arteevo primarily joins consortia as a technology partner (3 out of 4 projects as participant), contributing platform and blockchain development expertise to larger teams. They coordinated one small SME Instrument project (GASTEJO, €50K), suggesting they are comfortable leading their own product initiatives but more typically serve as a specialist contributor in larger Innovation and Research Actions. With 44 unique partners across 16 countries, they are well-networked and open to diverse international collaborations rather than sticking to a fixed set of partners.

Arteevo has built a broad European network of 44 unique consortium partners spanning 16 countries — unusually wide for a 4-project SME, reflecting participation in large-scale Innovation Actions. Their geographic reach extends well beyond Israel into mainstream European R&D consortia.

What sets them apart

Arteevo brings a rare combination: blockchain platform architecture applied across wildly different sectors — manufacturing, travel, privacy, and pharma — all within a small, agile SME structure. For consortium builders, this means a partner that can adapt blockchain and digital marketplace expertise to virtually any industry vertical without needing a long ramp-up. Their PharmaLedger involvement (€906K, their largest grant) signals that major consortia trust them with significant technical responsibilities despite their small size.

Highlights from their portfolio

• PharmaLedger
  Their largest project by far (€906K), applying blockchain to combat counterfeit medicines and build ML-driven health data marketplaces — signals a serious pivot into health-tech.
• WeldGalaxy
  Demonstrates their platform-building versatility: a digital knowledge platform for the welding industry combining blockchain, cloud resources, APIs, and lifecycle assessment tools.
• GASTEJO
  Their only coordinated project — a decentralized travel platform funded through SME Instrument Phase 1, showing entrepreneurial initiative beyond consortium participation.